All Updates

All Updates

icon
Filter
Funding
nference raises USD 60 million in Series C funding
AI Drug Discovery
Dec 15, 2020
This week:
Product updates
Nintendo ventures into MMOs with new Switch Online game playtest
Metaverse Experience Platforms
Yesterday
Product updates
HP releases texture library for 3D printing with CoreTechnologie 4D Additive
Additive Manufacturing
Oct 21, 2024
Partnerships
Honeywell partners with Google to bring Gemini AI to industrial sector
Smart Factory
Oct 21, 2024
Product updates
xAI launches API for third-party developers to access Grok models
Foundation Models
Oct 21, 2024
Partnerships
Nava Benefits partners with OpenAI to launch AI-powered benefits assistant
Foundation Models
Oct 21, 2024
Product updates
IBM releases Granite 3.0 AI models for enterprise use
Foundation Models
Oct 21, 2024
Partnerships
Honeywell partners with Google to bring Gemini AI to industrial sector
Foundation Models
Oct 21, 2024
M&A
Inflection AI acquires Boundaryless for undisclosed sum to accelerate enterprise AI deployments
Foundation Models
Oct 21, 2024
Industry news
News Corp sues Perplexity AI for alleged copyright infringement
Generative AI Applications
Oct 21, 2024
Product updates
Haiper debuts new video generation model
Generative AI Applications
Oct 21, 2024
AI Drug Discovery

AI Drug Discovery

Dec 15, 2020

nference raises USD 60 million in Series C funding

Funding

  • Massachusetts-based nference has raised USD 60 million in Series C funding led by Matrix Capital Management, with participation from Matrix Partners, Mayo Clinic Ventures, and NTTVC. 

  • nference intends to use the proceeds to advance the development of software and learning models on its nferX software platform, enabling novel diagnostics and therapeutics. 

  • Founded in 2013, nference operates a biomedical knowledge synthesis platform that captures and analyzes health data, including unstructured information to help researchers in drug discovery. Its AI-powered platform uses neural networks (shallow and deep learning models) for the automatic extraction of insights from clinical notes, scientific literature, pathology images, ECG waveforms, and genomic sequences.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.